Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
0 hedge funds and large institutions have $0 invested in Enzo Biochem, Inc. in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 7 closing their positions.
100% less funds holding
Funds holding: 7 → 0 (-7)
100% less capital invested
Capital invested by funds: $2M → $0 (-$2M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 7
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OBAM
ODDO BHF Asset Management
Paris,
France
|
-$1.75M |
| 2 |
RC
RBF Capital
San Francisco,
California
|
-$102K |
| 3 |
Squarepoint
New York
|
-$95.4K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$30.4K |
| 5 |
KCM
Kempner Capital Management
Galveston,
Texas
|
-$17K |
ENZ Hedge Fund Activity: Q3 2025 in Review
0 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q3 2025, worth a combined $0 — down 100% from $2M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ENZ and 0 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was ODDO BHF Asset Management, exiting entirely with an estimated $1.75M sold.
- 0 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q3 2025, down from 7 in Q2 2025.
- Funds reported $0 of Enzo Biochem, Inc. stock for Q3 2025, down 100% quarter-over-quarter.
- 0 funds opened new Enzo Biochem, Inc. positions in Q3 2025 and 7 closed out, a net change of -7 holders.
- The largest Enzo Biochem, Inc. seller in Q3 2025 was ODDO BHF Asset Management, an estimated $1.75M sold.
Based on aggregated 13F filings for Q3 2025.